dimenium 50 mikrograma + 100 mikrograma u jednoj dozi, prašak inhalata, dozirani
elpen pharmaceutical co.inc. (sa), 95, marathonos ave., pikermi, attica, grčka - salmeterolksinafoat flutikazonpropionat - prašak inhalata, dozirani - 50 mikrograma + 100 mikrograma - urbroj: jedna doza praška inhalata sadrži 50 mikrograma salmeterola u obliku salmeterolksinafoata i 100 mikrograma flutikazonpropionata
pinmirol 10 mg/ 10 mg tvrde kapsule
genericon pharma gesellschaft m.b.h., hafnerstraße 211, graz, austrija - ramipril amlodipinbesilat - kapsula, tvrda - 10 mg + 10 mg - urbroj: jedna kapsula sadrži 10 mg ramiprila i 10 mg amlodipina (u obliku amlodipinbesilata)
ketonal 100 mg čepići
sandoz d.o.o., maksimirska 120, zagreb, hrvatska - ketoprofen - čepić - 100 mg - urbroj: jedan čepić sadrži 100 mg ketoprofena
palonozetron kalceks 250 mikrograma otopina za injekciju
as kalceks, krustpils iela 71e, riga, latvija - palonozetronklorid - otopina za injekciju - urbroj: jedan ml otopine sadrži 50 mikrograma palonozetrona (u obliku palonozetronklorida) jedna bočica otopine od 5 ml sadrži 250 mikrograma palonozetrona (u obliku palonozetronklorida)
ringerova otopina braun 8.6 g/1000 ml+ 0.3 g/1000 ml+ 0.33 g/1000 ml otopina za infuziju
b.braun adria bh d.o.o. - kalcijumhlorid, kalijumhlorid, natrijumhlorid - otopina za infuziju - 8.6 g/1000 ml+ 0.3 g/1000 ml+ 0.33 g/1000 ml - 1000 ml otopine za infuziju sadrži: 8,6 g natrijumhlorid 0,3 g kalijumhlorid 0,33 g kalcijumhlorid, dihidrat
ringerova otopina braun 8.6 g/1000 ml+ 0.3 g/1000 ml+ 0.33 g/1000 ml otopina za infuziju
b.braun adria bh d.o.o. - kalcijumhlorid, kalijumhlorid, natrijumhlorid - otopina za infuziju - 8.6 g/1000 ml+ 0.3 g/1000 ml+ 0.33 g/1000 ml - 1000 ml otopine sadrži; 8,6 g natrijumhlorid 0,30 g kalijumhlorid 0,33 g kalcijumhlorid, dihidrat
pemetrexed pfizer (previously pemetrexed hospira)
pfizer europe ma eeig - pemetrexed disodium, pemetrexed disodium hemipentahydrate - carcinoma, non-small-cell lung; mesothelioma - antineoplastična sredstva - malignant pleural mesotheliomapemetrexed pfizer in combination with cisplatin is indicated for the treatment of chemotherapy naïve patients with unresectable malignant pleural mesothelioma. non-small cell lung cancerpemetrexed pfizer in combination with cisplatin is indicated for the first-line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology. pemetrexed pfizer is indicated as monotherapy for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology in patients whose disease has not progressed immediately following platinum-based chemotherapy. pemetrexed pfizer is indicated as monotherapy for the second-line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology.
zynlonta
swedish orphan biovitrum ab - loncastuximab tesirine - lymphoma, large b-cell, diffuse; lymphoma, b-cell - antineoplastična sredstva - zynlonta as monotherapy is indicated for the treatment of adult patients with relapsed or refractory diffuse large b-cell lymphoma (dlbcl) and high-grade b-cell lymphoma (hgbl), after two or more lines of systemic therapy.
dimenium 50 mikrograma + 250 mikrograma u jednoj dozi, prašak inhalata, dozirani
elpen pharmaceutical co.inc. (sa), 95, marathonos ave., pikermi, attica, grčka - salmeterolksinafoat flutikazonpropionat - prašak inhalata, dozirani - 50 mikrograma + 250 mikrograma - urbroj: jedna doza praška inhalata sadrži 50 mikrograma salmeterola u obliku salmeterolksinafoata i 250 mikrograma flutikazonpropionata
dimenium 50 mikrograma + 500 mikrograma u jednoj dozi, prašak inhalata, dozirani
elpen pharmaceutical co.inc. (sa), 95, marathonos ave., pikermi, attica, grčka - salmeterolksinafoat flutikazonpropionat - prašak inhalata, dozirani - 50 mikrograma + 500 mikrograma - urbroj: jedna doza praška inhalata sadrži 50 mikrograma salmeterola u obliku salmeterolksinafoata i 500 mikrograma flutikazonpropionata